Pliant Therapeutics Inc (PLRX)
$13.30 -$0.58 (-4.22%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$893.94M -
Day's Range
$13.20 - $13.69 -
Volume
426,453 -
52 Week Low / High
$10.22 - $19.62 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
PLRX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 8
- Strong Buy
- 5
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $46.57
- Target Price
Company News
-
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer — Sep 24th, 2024
Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the ...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$